HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rational design of an EGF-IL18 fusion protein: implication for developing tumor therapeutics.

Abstract
Interleukin-18 (IL-18) is a proinflammatory cytokine. This protein has a role in regulating immune responses and exhibits significant anti-tumor activities. Epidermal growth factor (EGF) is an important growth factor that plays a central role in the regulation of cell cycle and differentiation. It was proposed that a targeted delivery of IL-18 by generation of IL-18-EGF fusion protein might decrease adverse effects and result in enhancing cytotoxic and antitumor activities. In the present study, a fusion protein, consisting of EGFR binding domain fused to human IL-18 mature peptide via a linker peptide of (Gly(4)Ser) 3, was constructed and expressed in the insect cell line Sf9 using Bac-to-Bac baculovirus expression system. We showed that the purified recombinant fusion protein induced similar levels of IFN-gamma to that of native IL-18 protein in human PBMC in the presence of ConA. Furthermore, EGF receptor competitive test in human epithelial cancer A431 cell line showed that EGF-IL18 fusion protein can specifically bind with EGFR by competing with native EGF protein. These suggest that this rationally designed protein can be further developed as novel tumor therapeutics.
AuthorsJian-Xin Lu, Ying Peng, Zhe-Feng Meng, Li-Qin Jin, Yong-Sui Lu, Min-Xin Guan
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 334 Issue 1 Pg. 157-61 (Aug 19 2005) ISSN: 0006-291X [Print] United States
PMID15993840 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-18
  • Recombinant Fusion Proteins
  • Epidermal Growth Factor
  • ErbB Receptors
Topics
  • Animals
  • Carcinoma, Squamous Cell (genetics, metabolism, therapy)
  • Cell Line
  • Drug Delivery Systems (methods)
  • Drug Design
  • Epidermal Growth Factor (genetics, metabolism, therapeutic use)
  • ErbB Receptors (metabolism)
  • Gene Targeting (methods)
  • Humans
  • Interleukin-18 (genetics, metabolism, therapeutic use)
  • Protein Engineering (methods)
  • Recombinant Fusion Proteins (metabolism)
  • Spodoptera (genetics, metabolism)
  • Transfection (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: